Exa Noma is a preclinical biopharmaceutical company developing novel medicines to treat glioblastoma.
https://www.cell.com/iscience/fulltext/S2589-0042(23)00764-2
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Find investors for your startup like Exa Noma Therapeutics
Gritt sends AI-personalised outreach to each investor — from your Gmail
